SGLT-2 Inhibitors Cut Risk Of Death In Diabetics, Data Shows | Latest News RSS feed

SGLT-2 Inhibitors Cut Risk Of Death In Diabetics, Data Shows - Latest News


SGLT-2 inhibitors cut risk of death in diabetics, data shows

AstraZeneca has unveiled findings of a new analysis of data from the CVD-REAL study, showing a significant cut in the risk of all-cause death (ACD) in patients with type II diabetes taking SGLT-2 inhi... read more

Real-world study shows type 2 diabetics treated with SGLT-2 inhibitors experienced less risk of hospitalization for heart failure and death

The data showed that treatment with SGLT-2 inhibitors ... and death from any cause by 51% (hazard ratio = 0.49; p<0.001). For the composite endpoint of hospitalization for heart failure and all-cause ... read more

Newer type 2 diabetes drugs show heart protective quality in study

WASHINGTON (Reuters) - A newer class of type 2 diabetes drugs significantly cut the risk of death and ... according to data released on Sunday from a so-called real world study sponsored by AstraZenec... read more

Looking for another news?


Newer type 2 diabetes drugs show heart protective quality: study

The drugs, known as SGLT-2 inhibitors ... diabetes. (Representational Image) A newer class of type 2 diabetes drugs significantly cut the risk of death and hospitalization for heart failure compared w... read more


Newer type 2 diabetes drugs show heart protective quality in study

WASHINGTON, March 19 (Reuters) - A newer class of type 2 diabetes drugs significantly cut the risk of death ... to data released on Sunday from a so-called real world study sponsored by AstraZeneca (N... read more

Trial shows heart benefits of Novo’s diabetes drug Victoza

Hotly-anticipated data on Novo Nordisk's diabetes therapy Victoza show that the drug significantly cut the risk ... of death worldwide in this patient population." The drug now joins the ranks of Eli ... read more

J&J diabetes drug shows heart benefit in large safety study

(Reuters) - Johnson & Johnson’s type 2 diabetes drug Invokana significantly reduced the risk of serious heart problems in patients with established heart disease or at elevated risk in a pair of large ... read more



FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us